摘要
Abstract
Objective: Discussion clinical efficacy of moderate to severe chronic obstructive pulmonary disease (COPD) with Seretide joint Montelukast treatment. Methods : 74 patients with moderate to severe COPD were randomly divided into the aminophylline group, Seretide group and Seretide joint Montelukast group. The three groups were given treatment with aminophylline, Seretide and Seretide joint Montelukast. Before and after treatment, The three groups were assessed with 6min walk test, pulmonary function test and the number of annual inpatients of the groups was counted ,the three groups were followed 4 years, and then the results were compared. Results: Comparison between the three groups, the pulmonary function of the Seretide group and the Seretide joint Montelukast group with 6min walk test were significantly improved(P＜0. 05) , the annual inpatients of the pulmonary function of the Seretide group were significantly decreased (P＜0. 05). Conclusion : Seretide is a moderate to severe COPD in stable and effective treatment modalities; Seretide joint Montelukast in the treatment of moderate to severe COPD in stable synergistic effect.关键词
肺疾病,慢性阻塞性/药物疗法/肾上腺素能/β激动剂/治疗应用/糖皮质激素类/治疗应用Key words
Pulmonary disease, chronic obstructive/drug/ therapy Adrenergic/ beta-agonists/therapeutic use /Glucocorticoids/therapeutic use分类
医药卫生
